Funding Status: N/A
Industry: Gene Therapy
Estimated Revenue: $10M to $50M
Technology: Cancer
Number Of Exists: Venture - Series Unknown
Headquarters: Abingdon, Oxfordshire, United Kingdom
Total Funding: $102.5M
Last Funding Type: Venture - Series Unknown
Investor Type: Company
Employee Number: 51-100
Investors Number: 7
Investment Stage: N/A
Founded Date: 2006